
Opinion|Videos|June 24, 2024
Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the role of fusion-guided biopsy in determining patient eligibility for focal therapy?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5




















